Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xian-Yang Li

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Molecular & Cellular Oncology|June 17, 2016
Tumor suppressor activity of RIG-IXian-Yang Li, He-Zhou Guo, Jiang Zhu
Nature Reviews. Immunology|July 31, 2020
Targeting CD39 in cancerAchim K Moesta, Xian-Yang Li, Mark J Smyth
Seminars in Cancer Biology|December 30, 2019
Tumor intrinsic and extrinsic immune functions of CD155Jake S O'Donnell, Jason Madore, Xian-Yang Li, et al.
Biomedical and Environmental Sciences : BES|April 27, 2023
rs3735664 Polymorphism Affecting <i>ELFN1-AS1</i> Adsorption on miR-1231 is Associated with Colorectal Cancer Susceptibility and Tumor StageXian Yang Li, Zhi Jun Huang, Jian Ping Li, et al.
Biomedical and Environmental Sciences : BES|January 18, 2023
Association between the Missense Variant of <i>PLCE1</i> and the Risk of Colorectal CancerXue Ren Gao, Jun Jie Pan, Wan Jia Nie, et al.
Cancer Letters|July 23, 2022
CD155 in tumor progression and targeted therapyMeixiao Zhan, Zhiren Zhang, Xiaoguang Zhao, et al.
Biomedical and Environmental Sciences : BES|September 21, 2022
Clinical Significance and Function of <i>MALAT1</i> Gene Expression and the rs619586 Polymorphism in Colorectal CancerXue Ren Gao, Xin Yu Wang, Xian Yang Li, et al.
Oncoimmunology|May 10, 2019
The role of NK cells and CD39 in the immunological control of tumor metastasesHaiyan Zhang, Dipti Vijayan, Xian-Yang Li, et al.
Frontiers in Immunology|January 30, 2023
Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinomaWenting Li, Xiaobing Duan, Xingxing Chen, et al.
International Immunopharmacology|November 18, 2023
The persistence and antitumor efficacy of CAR-T cells are modulated by tonic signaling within the CDRJincai Zhou, Feifei Shi, Xinran Luo, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Molecular & Cellular Oncology|June 17, 2016
Tumor suppressor activity of RIG-IXian-Yang Li, He-Zhou Guo, Jiang Zhu
Nature Reviews. Immunology|July 31, 2020
Targeting CD39 in cancerAchim K Moesta, Xian-Yang Li, Mark J Smyth
Seminars in Cancer Biology|December 30, 2019
Tumor intrinsic and extrinsic immune functions of CD155Jake S O'Donnell, Jason Madore, Xian-Yang Li, et al.
Biomedical and Environmental Sciences : BES|April 27, 2023
rs3735664 Polymorphism Affecting <i>ELFN1-AS1</i> Adsorption on miR-1231 is Associated with Colorectal Cancer Susceptibility and Tumor StageXian Yang Li, Zhi Jun Huang, Jian Ping Li, et al.
Biomedical and Environmental Sciences : BES|January 18, 2023
Association between the Missense Variant of <i>PLCE1</i> and the Risk of Colorectal CancerXue Ren Gao, Jun Jie Pan, Wan Jia Nie, et al.
Cancer Letters|July 23, 2022
CD155 in tumor progression and targeted therapyMeixiao Zhan, Zhiren Zhang, Xiaoguang Zhao, et al.
Biomedical and Environmental Sciences : BES|September 21, 2022
Clinical Significance and Function of <i>MALAT1</i> Gene Expression and the rs619586 Polymorphism in Colorectal CancerXue Ren Gao, Xin Yu Wang, Xian Yang Li, et al.
Oncoimmunology|May 10, 2019
The role of NK cells and CD39 in the immunological control of tumor metastasesHaiyan Zhang, Dipti Vijayan, Xian-Yang Li, et al.
Frontiers in Immunology|January 30, 2023
Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinomaWenting Li, Xiaobing Duan, Xingxing Chen, et al.
International Immunopharmacology|November 18, 2023
The persistence and antitumor efficacy of CAR-T cells are modulated by tonic signaling within the CDRJincai Zhou, Feifei Shi, Xinran Luo, et al.
Pageof 3